icon-folder.gif   Conference Reports for NATAP  
 
  17th International Workshop
on Clinical Pharmacology of
HIV and Hepatitis Therapy
June 8-10, 2016, Washington DC
Back grey_arrow_rt.gif
 
 
 
No Clinically Significant Interaction of MK-3682 With the HIV Medications Dolutegravir, Raltegravir, Rilpivirine, and Tenofovir Disoproxil Fumarate
 
 
  Reported by Jules Levin
 
The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy Washington, DC
June 8-10, 2016
 
Wei Gao; Leticia Arrington; Xiaoli Shirley Glasgow; Julie Luk; Elizabeth G. Rhee; William L. Marshall; Nancy Kim*; Marian Iwamoto; and Eugene E. Marcantonio *Corresponding author Merck & Co., Inc., Kenilworth, NJ, USA

Clin1

Clin2

Clin3

Clin4

Clin5

Clin6

Clin7

Clin8

Clin9